Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001569052-13-000001
Filing Date
2013-03-13
Accepted
2013-03-13 11:05:13
Documents
1
Effectiveness Date
2013-03-13
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8221
  Complete submission text file 0001569052-13-000001.txt   9233
Mailing Address 1300 YORK AVENUE NEW YORK NY 10065
Business Address 1300 YORK AVENUE NEW YORK NY 10065 (650) 463-3069
Angiocrine Bioscience, Inc. (Filer) CIK: 0001569052 (see all company filings)

EIN.: 460855286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-193195 | Film No.: 13686387